These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28488841)

  • 1. Catastrophic antiphospholipid syndrome: an update.
    Espinosa G; Rodríguez-Pintó I; Cervera R
    Panminerva Med; 2017 Sep; 59(3):254-268. PubMed ID: 28488841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry".
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Med Clin (Barc); 2024 Aug; 163 Suppl 1():S31-S35. PubMed ID: 39174151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab.
    Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G;
    Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catastrophic antiphospholipid syndrome: The current management approach.
    Rodriguez-Pintó I; Espinosa G; Cervera R
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):239-249. PubMed ID: 27886797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of refractory cases of catastrophic antiphospholipid syndrome.
    Espinosa G; Berman H; Cervera R
    Autoimmun Rev; 2011 Sep; 10(11):664-8. PubMed ID: 21569863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death, and prognostic factors.
    Espinosa G; Bucciarelli S; Asherson RA; Cervera R
    Semin Thromb Hemost; 2008 Apr; 34(3):290-4. PubMed ID: 18720310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
    Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
    J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catastrophic antiphospholipid syndrome].
    Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review.
    Cervera R; Rodríguez-Pintó I; Espinosa G
    J Autoimmun; 2018 Aug; 92():1-11. PubMed ID: 29779928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of catastrophic antiphospholipid syndrome.
    Kazzaz NM; McCune WJ; Knight JS
    Curr Opin Rheumatol; 2016 May; 28(3):218-27. PubMed ID: 26927441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry".
    López-Benjume B; Rodríguez-Pintó I; Amigo MC; Erkan D; Shoenfeld Y; Cervera R; Espinosa G;
    Autoimmun Rev; 2022 Apr; 21(4):103055. PubMed ID: 35085802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus.
    González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L
    Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
    Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V
    J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement.
    Rymarz A; Niemczyk S
    BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome.
    Bucciarelli S; Espinosa G; Cervera R
    Lupus; 2009 Sep; 18(10):905-12. PubMed ID: 19671791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease.
    Unlu O; Erkan D
    Annu Rev Med; 2017 Jan; 68():287-296. PubMed ID: 28099080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.
    Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A
    Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of catastrophic antiphospholipid syndrome.
    Carmi O; Berla M; Shoenfeld Y; Levy Y
    Expert Rev Hematol; 2017 Apr; 10(4):365-374. PubMed ID: 28277850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange in catastrophic antiphospholipid syndrome.
    Rodríguez-Pintó I; Lozano M; Cid J; Espinosa G; Cervera R
    Presse Med; 2019 Nov; 48(11 Pt 2):347-353. PubMed ID: 31694791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.